Newcastle fashion retailer aims for expansion following acquisition by US firm
A multinational investment company has announced that it has acquired a majority stake in a North East fashion retailer.
END, a luxury, streetwear and sportswear retailer headquartered in Newcastle, has been acquired by The Carlyle Group, an investment company based in the United States.
The companies have said that the acquisition will support END’s expansion nationally and internationally.
END currently has annual revenues of around £170m, employing more than 650 people in the UK.
Law firm Womble Bond Dickinson (WBD) has advised END. on the acquisition.
WBD partner Ben Butler commented: “We are all immensely proud to have been involved in advising Christiaan and John [founders of END] on this latest transformational transaction.
“Carlyle Group’s investment will allow the acceleration of END.’s growth plans and we are all extremely excited about the future for this stand out North East brand.
“We are always delighted to be able to support clients throughout their corporate journey and help to deliver their key strategic objectives.”
Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →
Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.
Enjoy the read? Get Bdaily delivered.
Sign up to receive our daily bulletin, sent to your inbox, for free.
Improving North East transport will improve lives
Unlocking investment potential before year end
Give us certainty to deliver better homes
Hormuz: Safe passage - not insurance - the issue
Don't get caught out by employment law change
When literacy thrives, our businesses thrive too
Building a more diverse construction sector
The value of using data like a Premier League club
Raising the bar to boost North East growth
Navigating the messy middle of business growth
We must make it easier to hire young people
Why community-based care is key to NHS' future